Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Sanders

Showing results (51-60 of 154) with videos related to

Pageof 16
Sort By:
Antimicrobial Agents and Chemotherapy|September 1, 1994
Dissociated resistance among fluoroquinolonesK S Thomson, C C Sanders
Antimicrobial Agents and Chemotherapy|September 1, 1992
Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional testsK S Thomson, C C Sanders
Reviews of Infectious Diseases|July 1, 1983
Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the futureC C Sanders, W E Sanders
Antimicrobial Agents and Chemotherapy|January 1, 1990
Diverse potential of beta-lactamase inhibitors to induce class I enzymesD A Weber, C C Sanders
The Journal of Infectious Diseases|November 1, 1982
Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococciC C Sanders, W E Sanders
The Journal of International Medical Research|January 1, 1981
Sisomicin: an aminoglycoside antibiotic that is highly effective against PseudomonasW E Sanders, C C Sanders
The Journal of Antimicrobial Chemotherapy|September 17, 1998
The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolonesK S Thomson, C C Sanders
The Journal of Antimicrobial Chemotherapy|January 1, 1986
Trapping and hydrolysis are not mutually exclusive mechanisms for beta-lactamase-mediated resistanceC C Sanders, W E Sanders
Journal of Clinical Microbiology|April 1, 1990
Relevant breakpoints for ticarcillin-clavulanic acid should be set primarily with data from ticarcillin-resistant strainsC C Sanders, S J Cavalieri
Antimicrobial Agents and Chemotherapy|May 1, 1999
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic modelP D Lister, C C Sanders
Pageof 16

Showing results (51-60 of 154) with videos related to

Sort By:
Pageof 16
Antimicrobial Agents and Chemotherapy|September 1, 1994
Dissociated resistance among fluoroquinolonesK S Thomson, C C Sanders
Antimicrobial Agents and Chemotherapy|September 1, 1992
Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional testsK S Thomson, C C Sanders
Reviews of Infectious Diseases|July 1, 1983
Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the futureC C Sanders, W E Sanders
Antimicrobial Agents and Chemotherapy|January 1, 1990
Diverse potential of beta-lactamase inhibitors to induce class I enzymesD A Weber, C C Sanders
The Journal of Infectious Diseases|November 1, 1982
Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococciC C Sanders, W E Sanders
The Journal of International Medical Research|January 1, 1981
Sisomicin: an aminoglycoside antibiotic that is highly effective against PseudomonasW E Sanders, C C Sanders
The Journal of Antimicrobial Chemotherapy|September 17, 1998
The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolonesK S Thomson, C C Sanders
The Journal of Antimicrobial Chemotherapy|January 1, 1986
Trapping and hydrolysis are not mutually exclusive mechanisms for beta-lactamase-mediated resistanceC C Sanders, W E Sanders
Journal of Clinical Microbiology|April 1, 1990
Relevant breakpoints for ticarcillin-clavulanic acid should be set primarily with data from ticarcillin-resistant strainsC C Sanders, S J Cavalieri
Antimicrobial Agents and Chemotherapy|May 1, 1999
Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic modelP D Lister, C C Sanders
Pageof 16